Radiology reports that suggest further imaging are more likely to result in a lack of follow-up care than those without, according to a study published online Jan. 10 in the Journal of the American College of Radiology.

Fort Lee, New Jersey, January 8, 2015 – Rayence Inc. announced the appointment of Bill Cioffi as Vice President of Business Development. Cioffi, an industry veteran who spent the majority of 35 year career in management positions at Fujifilm Medical Systems and later Del Medical, joined Rayence in mid-2014 as Director of Sales and Marketing.

Papworth Hospital NHS Foundation Trust has officially unveiled a SOMATOM® Force in its Radiology Department to bolster its cardiac imaging services. The new technology was launched by Cambridge MP Dr Julian Huppert at the official opening of the system. The CT imaging system will benefit patients by using the lowest achievable dose and provide patients who suffer with shortness of breath with rapid scanning. With approximately half of all the hospital’s CT imaging consisting of cardiac procedures, it is anticipated the system will increase cardiac throughput.

While providers assume patients want shorter wait times and comfortable surroundings, patients were actually more concerned with feelings of support from their care team and developing an inter-personal relationship with providers, according to a recent survey published online Dec. 20 in the Journal of the American College of Radiology.

FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (FDBU), a FUJIFILM Corporation subsidiary, today announced the completion of its acquisition of Kalon Biotherapeutics LLC, marking an important new chapter in the emergence of the Texas biosciences industry as a center for world-class development and manufacturing of life-saving biopharmaceuticals and biotechnology while providing FUJIFILM Diosynth Biotechnologies with expanded capacity for its growing vaccine capabilities. The completion of the previously announced Purchase Interest Agreement of Kalon Biotherapeutics, LLC, was made with the owners of Kalon: the State of Texas, acting by and through the Office of the Governor, and The Texas A&M University System. The announcement was made jointly today by Governor Rick Perry; officials of FUJIFILM Corporation, FDBU and Mitsubishi Corporation; Kalon Biotherapeutics LLC; and the Texas A&M System. Going forward, the company is now known as FUJIFILM Diosynth Biotechnologies Texas, LLC.

Royal Philips (NYSE: PHG; AEX: PHIA) and Volcano Corporation (NASDAQ:VOLC), a global leader in catheter-based imaging and measurement solutions for cardiovascular applications, today announced that they have entered into a definitive merger agreement. Pursuant to the agreement, Philips will commence a tender offer to acquire all of the issued and outstanding shares of Volcano for USD 18.00 per share, or a total equity purchase price of USD 1 billion (approx. EUR 800 million), to be paid in cash upon completion. The board of directors of Volcano has unanimously approved the transaction and recommends the offer to its shareholders. The transaction is expected to close in the first quarter of 2015.

Millions of imaging tests are performed in the United States each year.  Although most of these exams are interpreted by a radiologist, patients usually receive their results from the ordering physician.  In many cases, the radiologist, as the imaging expert, is actually the physician best equipped to explain imaging findings. Lightbulb Radiology bridges this gap between the radiologist and the patient.

InnoLife, a consortium of 144 European companies, research institutes and universities, has been selected by the European Institute of Innovation and Technology (EIT) as the Knowledge and Innovation Community (KIC) for EIT Health. With a total volume of EUR 2.1 billion it is one of the largest public funded initiatives for health worldwide.